On April 21, 2025, Aptevo Therapeutics Inc. entered into a securities purchase agreement to sell 2,324,000 shares of common stock at $0.862 per share, raising approximately $1.8 million for working capital and clinical programs. The closing of this offering occurred on April 22, 2025.